Dear Students,
Below you can find the Scientific Students’ Association (TDK) and thesis topics announced for the 2025/2026 academic year by the faculty members of our Department and the associate researchers of the National Institute of Oncology. If a topic captures your interest, please click on the name of the respective supervisor to view their contact information.
Topic Titles:
- Sarcopenic obesity in tumor patients (Prof. Dr. Magdolna Dank Ph.D.)
- Co-occurrence of testicular cancer and sarcoidosis (Dr. Krisztina Biró Ph.D.)
- Initial experiences with retroperitoneal lymphadenectomy in patients with stage II seminoma (Dr. Krisztina Biró Ph.D.)
- The impact of social status on the long-term outlook of testicular tumor patients (Dr. Krisztina Biró Ph.D.)
- The effect of close oncological follow-up on the mental health status of testicular tumor patients (Dr. Krisztina Biró Ph.D.)
- Adjuvant therapy in high-risk malignant melanoma: comparison of the efficacy of targeted and immunotherapy (Dr. Kata Czirbesz Ph.D)
- Methodology development for measuring DPD enzyme activity (Dr. Tamás Ditrói and Prof. Dr. Péter Nagy Ph.D., D.Sc.)
- Robot-assisted esophageal surgeries (Dr. Zsolt Dubóczki)
- Radical pancreatic surgeries (Dr. Zsolt Dubóczki)
- Neoadjuvant treatment of testicular tumors (Dr. Lajos Géczi Ph.D.)
- Prognostic and predictive factors and treatment of adenoid cystic carcinoma (Dr. habil. Erika Hitre Ph.D. and Dr. Tamás Pintér Ph.D.)
- Hereditary gynecological malignant syndromes – screening, follow-up, prevention, genetic counseling – challenges and opportunities (Dr. Dániel Horányi Ph.D.)
- Prognostic significance of preoperative inflammatory parameters in endometrial cancer – a retrospective analysis (Dr. Dániel Horányi Ph.D.)
- Genetic profiling in gynecologic oncology (Dr. Dániel Horányi Ph.D.)
- Significance of Homologous Recombination Deficiency (HRD) in ovarian cancers – the role of PARP inhibitors (Dr. Dániel Horányi Ph.D.)
- Immunotherapy of urogenital tumors (Dr. Orsolya Horváth Ph.D.)
- Integration of active oncological treatment and palliative care (Dr. Orsolya Horváth Ph.D.)
- The impact of palliative interventions on the quality of life of cancer patients (Dr. Orsolya Horváth Ph.D.)
- Retrospective analysis of breast cancer patients under forty years of age (Dr. Orsolya Huszár Ph.D.)
- Complex therapy of malignant melanoma with cerebral metastases (Dr. Mihály Kispál Ph.D)
- Multivisceral resections in the treatment of retroperitoneal sarcomas (Dr. Tibor Kovács Ph.D.)
- Perioperative preparation during extensive radical oncological surgeries (Dr. Tibor Kovács Ph.D.)
- Clinicopathology of sex cord-stromal tumors of the testis (Dr. Levente Kuthi Ph.D.)
- Clinicopathology of renal tumors (Dr. Levente Kuthi Ph.D.)
- Molecular genetic alterations in prostate cancer (Dr. Levente Kuthi Ph.D.)
- The impact of PSMA PET/CT performed as part of primary staging on therapeutic decisions (Dr. Zsófia Küronya Ph.D)
- Efficacy comparison of triple and double combination treatment in patients with de novo high volume mHSPC (Dr. Zsófia Küronya Ph.D)
- Clinical aspects and prognostic factors of lymphoproliferative diseases (Dr. András Masszi Ph.D.)
- Primary bone lymphoma (Dr. András Masszi Ph.D., Dr. Tamás Schneider Ph.D. and Dr. Bálint Várnai)
- The role of minimally invasive surgery in the complex oncological treatment plan (Dr. Tamás Mersich Ph.D.)
- Laparoscopic and robot-assisted gastric cancer surgery (Dr. Tamás Mersich Ph.D.)
- New techniques in minimally invasive tumor surgery (Dr. Tamás Mersich Ph.D.)
- Limits of surgical radicality in complex oncological treatment (Dr. Tamás Mersich Ph.D.)
- Increasing efficiency in oncological surgery (Dr. Tamás Mersich Ph.D.)
- Psycho-neuro-immunological factors and surgical morbidity (Dr. Tamás Mersich Ph.D.)
- Critical evaluation of new technologies (Dr. Tamás Mersich Ph.D.)
- Robot-assisted liver surgeries (Dr. Tamás Mersich Ph.D. and Dr. Dániel Wettstein)
- HIPEC treatment and its results (Dr. Gergely Nagy)
- ELAPRE technique in rectal surgery (Dr. Gergely Nagy)
- Patient education and surgical outcome (Dr. Gergely Oláh)
- Investigation of the efficacy of CDK 4/6 inhibitors in metastatic breast cancer based on real-world data (Dr. Tamás Pintér Ph.D.)
- Investigation of modern therapy, predictive and prognostic markers of gastrointestinal tumors (Dr. Tamás Pintér Ph.D.)
- Laparoscopic rectal resections (Dr. Nándor Polk)
- Investigation of modern therapy, predictive and prognostic markers of breast tumors (Dr. Borbála Székely Ph.D.)
- Treatment of local recurrence of breast tumors (Dr. Borbála Székely Ph.D.)
- Radiomic analysis of tumors, radiogenomics (Dr. habil. Ádám Domonkos Tárnoki Ph.D. and Dr. habil. Dávid László Tárnoki Ph.D.)
- Investigation of primary resistance mechanisms against CDK 4/6 inhibitors in histological sections (Dr. József Tóvári Ph.D. and Dr. György Klément)
- Laparoscopic liver surgery (Dr. Dániel Wettstein)
Herausforderungen bei der Implementierung der Hepatic Arterial Infusion (HAI) Therapie in Europa (Dr. Wettstein Dániel)